GIA
Guyasuta Investment Advisors Portfolio holdings
AUM
$1.63B
This Quarter Return
+0.73%
1 Year Return
+20.57%
3 Year Return
+62.51%
5 Year Return
+123.21%
10 Year Return
+261.74%
AUM
$745M
AUM Growth
+$745M
(+0.39%)
Cap. Flow
+$663K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
31.21%
Holding
226
New
15
Increased
79
Reduced
63
Closed
17
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$13.3M |
| 2 |
McDonald's
MCD
|
$9.32M |
| 3 |
AbbVie
ABBV
|
$8.08M |
| 4 |
Qualcomm
QCOM
|
$3.48M |
| 5 |
CBPX
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
|
$1.3M |
Top Sells
| 1 |
Xylem
XYL
|
$15.4M |
| 2 |
Agilent Technologies
A
|
$12.8M |
| 3 |
CHMT
Chemtura Corporation
CHMT
|
$8.92M |
| 4 |
Lowe's Companies
LOW
|
$4.02M |
| 5 |
Cencora
COR
|
$3.56M |
Sector Composition
| 1 | Healthcare | 18.25% |
| 2 | Technology | 14.46% |
| 3 | Industrials | 12.33% |
| 4 | Consumer Discretionary | 10% |
| 5 | Energy | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Novartis
NVS
$248B
| $392K | 0.05% |
3,977
-615
| -13% | -$60.7K |
|
152
iShares Core S&P 500 ETF
IVV
$660B
| $375K | 0.05% |
1,804
-38
| -2% | -$7.9K |
|
153
Target
TGT
$42B
| $364K | 0.05% |
4,446
-74
| -2% | -$6.06K |
|
154
Northrop Grumman
NOC
$83.2B
| $360K | 0.05% |
2,238
| – | – |
|
155
Paychex
PAYX
$48.8B
| $355K | 0.05% |
7,162
+550
| +8% | +$27.3K |
|
156
Walt Disney
DIS
$211B
| $352K | 0.05% |
3,360
+157
| +5% | +$16.4K |
|
|
HQH
157
abrdn Healthcare Investors
HQH
$902M
| $348K | 0.05% |
10,000
| – | – |
|
158
Herc Holdings
HRI
$4.2B
| $344K | 0.05% |
15,880
-225
| -1% | -$4.87K |
|
|
TFCFA
159
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $343K | 0.05% |
+10,144
| New | +$343K |
|
|
CVC
160
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $340K | 0.05% |
18,605
-475
| -2% | -$8.68K |
|
|
LLTC
161
DELISTED
Linear Technology Corp
LLTC
| $327K | 0.04% |
+7,000
| New | +$327K |
|
162
Deere & Co
DE
$127B
| $320K | 0.04% |
3,650
| – | – |
|
163
Illinois Tool Works
ITW
$76.2B
| $312K | 0.04% |
3,222
| – | – |
|
164
iShares Core S&P Mid-Cap ETF
IJH
$99.4B
| $310K | 0.04% |
2,045
-145
| -7% | -$22K |
|
165
The Greenbrier Companies
GBX
$1.42B
| $310K | 0.04% |
5,345
-5,000
| -48% | -$290K |
|
166
iShares Global 100 ETF
IOO
$7.02B
| $307K | 0.04% |
+3,999
| New | +$307K |
|
167
Hillenbrand
HI
$1.75B
| $292K | 0.04% |
9,486
| – | – |
|
|
HRC
168
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $289K | 0.04% |
5,912
| – | – |
|
169
GSK
GSK
$79.3B
| $282K | 0.04% |
6,122
+1,250
| +26% | +$57.6K |
|
170
Teekay
TK
$709M
| $279K | 0.04% |
+6,000
| New | +$279K |
|
171
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $273K | 0.04% |
6,878
-1,400
| -17% | -$55.6K |
|
172
Wells Fargo
WFC
$258B
| $270K | 0.04% |
4,972
-450
| -8% | -$24.4K |
|
173
Suncor Energy
SU
$49.3B
| $269K | 0.04% |
9,228
| – | – |
|
174
Vanguard Total Bond Market
BND
$133B
| $269K | 0.04% |
3,231
+95
| +3% | +$7.91K |
|
175
Medtronic
MDT
$118B
| $267K | 0.04% |
+3,436
| New | +$267K |
|